3TC300mg+TDF300mg tabs/PAC-30 gb

General Description
Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg, equivalent to 245mg of Tenofovir Disoproxil, film coated tablets, bottle pack of 30
(gb = generic / bottle pack)

Technical Specifications
Each film coated tablet contains Lamivudine 300mg and Tenofovir Disoproxil fumarate 300mg which is equivalent to 245mg of Tenofovir Disoproxil.

Therapeutic class
Lamivudine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Standard shelf life
2 years (24 months)

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Indications
Management of HIV-1 infection in adults in combination with at least two other antiretroviral drugs. By mouth (oral), PO

Storage
Store at 25ºC (77ºF) in a tightly closed original container. Excursions permitted to 15-30ºC (59-86ºF).
Keep out of reach and sight of children.

Dispensing instructions
Dispense in original container. Do not repack
To be taken without regard to food

Regulatory Status
For latest updates check the list of Prequalified Medicines on the WHO website Prequalification Programme. apps.who.int/prequal/

For latest updates check the list of USFDA approved and tentatively approved items on the USFDA website. www.fda.gov/default.htm, www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/